168 related articles for article (PubMed ID: 32585841)
1. Effects of Pyrrole-Imidazole Polyamides Targeting Human TGF-β1 on the Malignant Phenotypes of Liver Cancer Cells.
Takagi K; Midorikawa Y; Takayama T; Abe H; Fujiwara K; Soma M; Nagase H; Miki T; Fukuda N
Molecules; 2020 Jun; 25(12):. PubMed ID: 32585841
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Study of Novel Gene Silencer Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Hypertrophic Scars in a Common Marmoset Primate Model.
Igarashi J; Fukuda N; Inoue T; Nakai S; Saito K; Fujiwara K; Matsuda H; Ueno T; Matsumoto Y; Watanabe T; Nagase H; Bando T; Sugiyama H; Itoh T; Soma M
PLoS One; 2015; 10(5):e0125295. PubMed ID: 25938472
[TBL] [Abstract][Full Text] [Related]
3. A pyrrole-imidazole polyamide targeting transforming growth factor-beta1 inhibits restenosis and preserves endothelialization in the injured artery.
Yao EH; Fukuda N; Ueno T; Matsuda H; Nagase H; Matsumoto Y; Sugiyama H; Matsumoto K
Cardiovasc Res; 2009 Mar; 81(4):797-804. PubMed ID: 19098300
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the EMT/MET process by pyrrole-imidazole polyamide targeting human transforming growth factor-β1.
Saito K; Fukuda N; Shinohara K; Masuhiro Y; Hanazawa S; Matsuda H; Fujiwara K; Ueno T; Soma M
Int J Biochem Cell Biol; 2015 Sep; 66():112-20. PubMed ID: 26222185
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional inhibition of hypertrophic scars by a gene silencer, pyrrole-imidazole polyamide, targeting the TGF-β1 promoter.
Washio H; Fukuda N; Matsuda H; Nagase H; Watanabe T; Matsumoto Y; Terui T
J Invest Dermatol; 2011 Oct; 131(10):1987-95. PubMed ID: 21654833
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset.
Otsuki M; Fukuda N; Inoue T; Mineshige T; Otsuki T; Horikoshi S; Endo M; Abe M
Molecules; 2019 Sep; 24(17):. PubMed ID: 31480595
[TBL] [Abstract][Full Text] [Related]
7. RNA binding properties of novel gene silencing pyrrole-imidazole polyamides.
Iguchi A; Fukuda N; Takahashi T; Watanabe T; Matsuda H; Nagase H; Bando T; Sugiyama H; Shimizu K
Biol Pharm Bull; 2013; 36(7):1152-8. PubMed ID: 23628892
[TBL] [Abstract][Full Text] [Related]
8. Development of multifunctional pyrrole-imidazole polyamides that increase hepatocyte growth factor and suppress transforming growth factor-β1.
Chen L; Fukuda N; Ueno T; Abe M; Matsumoto T
J Pharmacol Sci; 2024 Jan; 154(1):1-8. PubMed ID: 38081679
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel gene silencer pyrrole-imidazole polyamide targeting human connective tissue growth factor.
Wan JX; Fukuda N; Ueno T; Watanabe T; Matsuda H; Saito K; Nagase H; Matsumoto Y; Matsumoto K
Biol Pharm Bull; 2011; 34(10):1572-7. PubMed ID: 21963497
[TBL] [Abstract][Full Text] [Related]
10. Contribution of TGF-β1 and Effects of Gene Silencer Pyrrole-Imidazole Polyamides Targeting TGF-β1 in Diabetic Nephropathy.
Horikoshi S; Fukuda N; Tsunemi A; Okamura M; Otsuki M; Endo M; Abe M
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093382
[TBL] [Abstract][Full Text] [Related]
11. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases.
Matsuda H; Fukuda N; Ueno T; Tahira Y; Ayame H; Zhang W; Bando T; Sugiyama H; Saito S; Matsumoto K; Mugishima H; Serie K
J Am Soc Nephrol; 2006 Feb; 17(2):422-32. PubMed ID: 16371433
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional inhibition of progressive renal disease by gene silencing pyrrole-imidazole polyamide targeting of the transforming growth factor-β1 promoter.
Matsuda H; Fukuda N; Ueno T; Katakawa M; Wang X; Watanabe T; Matsui S; Aoyama T; Saito K; Bando T; Matsumoto Y; Nagase H; Matsumoto K; Sugiyama H
Kidney Int; 2011 Jan; 79(1):46-56. PubMed ID: 20861821
[TBL] [Abstract][Full Text] [Related]
13. Synthetic pyrrole-imidazole polyamide inhibits expression of the human transforming growth factor-beta1 gene.
Lai YM; Fukuda N; Ueno T; Matsuda H; Saito S; Matsumoto K; Ayame H; Bando T; Sugiyama H; Mugishima H; Serie K
J Pharmacol Exp Ther; 2005 Nov; 315(2):571-5. PubMed ID: 16120815
[TBL] [Abstract][Full Text] [Related]
14. Pyrrole-imidazole polyamide targeting transforming growth factor β1 ameliorates encapsulating peritoneal sclerosis.
Serie K; Fukuda N; Nakai S; Matsuda H; Maruyama T; Murayama Y; Omata S
Perit Dial Int; 2012; 32(4):462-72. PubMed ID: 22215658
[TBL] [Abstract][Full Text] [Related]
15. Krüppel-like factor 4 regulates stemness and mesenchymal properties of colorectal cancer stem cells through the TGF-β1/Smad/snail pathway.
Leng Z; Li Y; Zhou G; Lv X; Ai W; Li J; Hou L
J Cell Mol Med; 2020 Jan; 24(2):1866-1877. PubMed ID: 31830379
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
[TBL] [Abstract][Full Text] [Related]
18. A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function.
Ueno T; Fukuda N; Tsunemi A; Yao EH; Matsuda H; Tahira K; Matsumoto T; Matsumoto K; Matsumoto Y; Nagase H; Sugiyama H; Sawamura T
J Hypertens; 2009 Mar; 27(3):508-16. PubMed ID: 19330905
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 pathway affects the protein expression of many signaling pathways, markers of liver cancer stem cells, cytokeratins, and TERT in liver cancer HepG2 cells.
Wang XH; Liu MN; Sun X; Xu CH; Liu J; Chen J; Xu RL; Li BX
Tumour Biol; 2016 Mar; 37(3):3675-81. PubMed ID: 26462837
[TBL] [Abstract][Full Text] [Related]
20. Development of gene therapies for cardiovascular and renal diseases by nucleic acid medicines.
Fukuda N
Med Chem; 2006 Jan; 2(1):13-9. PubMed ID: 16787351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
